-
3
-
-
0023617615
-
Steroid scare
-
3 David TJ. Steroid scare. Arch Dis Child 1987; 62: 876-8.
-
(1987)
Arch Dis Child
, vol.62
, pp. 876-878
-
-
David, T.J.1
-
4
-
-
0002732887
-
Compliance problems in paediatric atopic eczema
-
4 Fischer G. Compliance problems in paediatric atopic eczema. Australas J Dermatol 1996; 37: S10-13.
-
(1996)
Australas J Dermatol
, vol.37
-
-
Fischer, G.1
-
5
-
-
0030744127
-
Adult height in patients with childhood onset atopic dermatitis
-
5 Patel L, Clayton PE, Jenney MEM et al. Adult height in patients with childhood onset atopic dermatitis. Arch Dis Child 1997; 76: 505-8.
-
(1997)
Arch Dis Child
, vol.76
, pp. 505-508
-
-
Patel, L.1
Clayton, P.E.2
Jenney, M.E.M.3
-
6
-
-
0016927925
-
The effect of percutaneously absorbed steroids on hypothalamic-pituitary-adrenal function after intensive use in in-patients
-
6 Munro DD. The effect of percutaneously absorbed steroids on hypothalamic-pituitary-adrenal function after intensive use in in-patients. Br J Dermatol 1976; 94 (Suppl. 12): 67-76.
-
(1976)
Br J Dermatol
, vol.94
, Issue.SUPPL. 12
, pp. 67-76
-
-
Munro, D.D.1
-
7
-
-
0023021367
-
Topical corticosteroid therapy for children: Aclometasone dipropionate cream 0.05%
-
7 Crespi HG. Topical corticosteroid therapy for children: aclometasone dipropionate cream 0.05%. Clin Ther 1986; 8: 203-10.
-
(1986)
Clin Ther
, vol.8
, pp. 203-210
-
-
Crespi, H.G.1
-
8
-
-
0030891884
-
Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis
-
8 Lucky AW, Grote GD, Williams JL et al. Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis. Cutis 1997; 59: 151-3.
-
(1997)
Cutis
, vol.59
, pp. 151-153
-
-
Lucky, A.W.1
Grote, G.D.2
Williams, J.L.3
-
9
-
-
0018098355
-
Percutaneous absorption of topically applied triamcinolone in children
-
9 Rasmussen JE. Percutaneous absorption of topically applied triamcinolone in children. Arch Dermatol 1978; 114: 1165-7.
-
(1978)
Arch Dermatol
, vol.114
, pp. 1165-1167
-
-
Rasmussen, J.E.1
-
10
-
-
0033016393
-
The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate
-
10 Van der Meer JB, Glazenburg EJ, Mulder PGH et al. The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. Br J Dermatol 1999; 140: 1114-21.
-
(1999)
Br J Dermatol
, vol.140
, pp. 1114-1121
-
-
Van Der Meer, J.B.1
Glazenburg, E.J.2
Mulder, P.G.H.3
-
11
-
-
0025780355
-
Comparison of mometasone furoate 0.01% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis
-
11 Vernon HJ, Lane AT, Weston W. Comparison of mometasone furoate 0.01% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis. J Am Acad Dermatol 1991; 24: 603-7.
-
(1991)
J Am Acad Dermatol
, vol.24
, pp. 603-607
-
-
Vernon, H.J.1
Lane, A.T.2
Weston, W.3
-
12
-
-
0018831512
-
Morning plasma cortisol levels in infants treated with topical fluorinated glucocorticosteroids
-
12 Weston WL, Sams WM, Morris HG et al. Morning plasma cortisol levels in infants treated with topical fluorinated glucocorticosteroids. Pediatrics 1980; 65: 103-6.
-
(1980)
Pediatrics
, vol.65
, pp. 103-106
-
-
Weston, W.L.1
Sams, W.M.2
Morris, H.G.3
-
13
-
-
0021152544
-
Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood
-
13 Queille C, Pommarede R, Saurat JH. Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood. Pediatr Dermatol 1984; 1: 246-53.
-
(1984)
Pediatr Dermatol
, vol.1
, pp. 246-253
-
-
Queille, C.1
Pommarede, R.2
Saurat, J.H.3
-
14
-
-
0030076217
-
Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema
-
14 Juhlin L. Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema. Cutis 1996; 57: 51-6.
-
(1996)
Cutis
, vol.57
, pp. 51-56
-
-
Juhlin, L.1
-
15
-
-
0028998556
-
Adrenal function following topical steroid treatment in children with atopic dermatitis
-
15 Patel L, Clayton PE, Addison GM et al. Adrenal function following topical steroid treatment in children with atopic dermatitis. Br J Dermatol 1995; 132: 950-5.
-
(1995)
Br J Dermatol
, vol.132
, pp. 950-955
-
-
Patel, L.1
Clayton, P.E.2
Addison, G.M.3
-
16
-
-
0028958735
-
In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid us compared to other potent topical glucocorticoids old and new
-
16 Kerscher MJ, Hart H, Korting HC et al. In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid us compared to other potent topical glucocorticoids old and new. Int J Clin Pharmacol Ther 1995; 33: 187-9.
-
(1995)
Int J Clin Pharmacol Ther
, vol.33
, pp. 187-189
-
-
Kerscher, M.J.1
Hart, H.2
Korting, H.C.3
-
17
-
-
0026763933
-
Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis
-
17 Kerscher MJ, Korting HC. Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis. Skin Pharmacol 1992; 5: 77-80.
-
(1992)
Skin Pharmacol
, vol.5
, pp. 77-80
-
-
Kerscher, M.J.1
Korting, H.C.2
-
18
-
-
0026600859
-
Topical glucocorticoids of the non-fluorinated double-ester type
-
18 Kerscher MJ, Korting HC. Topical glucocorticoids of the non-fluorinated double-ester type. Acta Derm Venereol (Stockh) 1992; 72: 214-16.
-
(1992)
Acta Derm Venereol (Stockh)
, vol.72
, pp. 214-216
-
-
Kerscher, M.J.1
Korting, H.C.2
-
19
-
-
0026571665
-
0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream
-
19 Korting HC, Vieluf D. Kerscher M. 0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream. Eur J Clin Pharmacol 1992; 42: 159-61.
-
(1992)
Eur J Clin Pharmacol
, vol.42
, pp. 159-161
-
-
Korting, H.C.1
Vieluf, D.2
Kerscher, M.3
|